Bioprocessing Fast Trak in South Korea

Biopharmaceutical and life sciences provider GE Healthcare Life Sciences business has opened a GE Fast Trak Centre in Songdo, Incheon Metropolitan City, South Korea.  The new USD 7.4 million Centre will support the growth of South Korea’s rapidly expanding biopharmaceutical industry by providing hands-on practical training, technology evaluation, manufacturing support and consultancy services in the latest strategies and technologies for upstream and downstream bioprocessing. 

Demand for GE’s newest Fast Trak Center is expected to be high, with estimates reported of a 9% growth in domestic biopharmaceutical production over the past five years, with an increase of around 34% in exports during 2014 and 2015. Songdo is already home to a number of leading South Korean biopharmaceutical companies and excellent national and international transport links will enable GE customers from other parts of the country and the wider Asia region, easy access to the services that the Centre has to offer.

Kieran Murphy, President and CEO of GE Healthcare’s Life Sciences business, said: “We’re delighted to be investing in South Korea with our fifth global Fast Trak Center, which brings us closer to our customers in one of the world’s key bioprocessing hubs, enabling us to share our global knowledge and expertise at a local level.  South Korea has some of the world’s most innovative biopharma companies and we look forward to further supporting the growth of the industry here.”